Approaches to improve photodynamic therapy of cancer.
暂无分享,去创建一个
D. Nowis | K. Bojarczuk | M. Winiarska | M. Firczuk | A. Szokalska | Malgorzata Jodlowska | M. Swiech | P. Salwa
[1] S. Kishi,et al. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy. , 2010, American journal of ophthalmology.
[2] W. Fong,et al. Phthalocyanine-polyamine conjugates as pH-controlled photosensitizers for photodynamic therapy. , 2010, Chemistry.
[3] Qian Peng,et al. Intracellular re-localisation by photochemical internalisation enhances the cytotoxic effect of gelonin--quantitative studies in normal rat liver. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[4] R. V. Omkumar,et al. Bioconjugated quantum dots for cancer research: present status, prospects and remaining issues. , 2010, Biotechnology advances.
[5] Jiahong Zhou,et al. A new sol-gel silica nanovehicle preparation for photodynamic therapy in vitro. , 2010, International journal of pharmaceutics.
[6] J. Usuda,et al. Management of Multiple Primary Lung Cancer in Patients with Centrally Located Early Cancer Lesions , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[7] T. Shuin,et al. Regulation of 5-Aminolevulinic Acid-Mediated Protoporphyrin IX Accumulation in Human Urothelial Carcinomas , 2009, Pathobiology.
[8] T. Hasan,et al. In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring , 2009, British Journal of Cancer.
[9] Y. Tsai,et al. Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[10] L. Davids,et al. Melanomas display increased cytoprotection to hypericin‐mediated cytotoxicity through the induction of autophagy , 2009, Cell biology international.
[11] M. Eljamel,et al. Photodynamic therapy adjuvant to surgery in metastatic carcinoma in brain. , 2009, Photodiagnosis and photodynamic therapy.
[12] W. Gallagher,et al. Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy , 2009, Photochemistry and photobiology.
[13] K. Berg,et al. Photochemical internalization (PCI) in cancer therapy: from bench towards bedside medicine. , 2009, Journal of photochemistry and photobiology. B, Biology.
[14] I D W Samuel,et al. An open pilot study of ambulatory photodynamic therapy using a wearable low‐irradiance organic light‐emitting diode light source in the treatment of nonmelanoma skin cancer , 2009, The British journal of dermatology.
[15] A. Oseroff,et al. Enhanced Systemic Immune Reactivity to a Basal Cell Carcinoma Associated Antigen Following Photodynamic Therapy , 2009, Clinical Cancer Research.
[16] M. Epple,et al. Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteria. , 2009, Biomaterials.
[17] Michael R Hamblin,et al. Anti-tumor immune response after photodynamic therapy , 2009, World Congress of the International Photodynamic Association.
[18] Michael R Hamblin,et al. Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. , 2009, Cancer research.
[19] Y. Urano,et al. Design and development of enzymatically activatable photosensitizer based on unique characteristics of thiazole orange. , 2009, Journal of the American Chemical Society.
[20] Kevin M. Smith,et al. The binding of analogs of porphyrins and chlorins with elongated side chains to albumin , 2009, European Biophysics Journal.
[21] F. Berr,et al. Photophysics and photochemistry of photodynamic therapy: fundamental aspects , 2009, Lasers in Medical Science.
[22] Xingping Zhou,et al. Studies on Preparation of Photosensitizer Loaded Magnetic Silica Nanoparticles and Their Anti-Tumor Effects for Targeting Photodynamic Therapy , 2009, Nanoscale research letters.
[23] Pingping Shen,et al. Methylene blue‐mediated photodynamic therapy induces mitochondria‐dependent apoptosis in HeLa Cell , 2008, Journal of cellular biochemistry.
[24] Yong Zhang,et al. Nanoparticles in photodynamic therapy: an emerging paradigm. , 2008, Advanced drug delivery reviews.
[25] Aleisha Elliott,et al. New Two-Photon Activated Photodynamic Therapy Sensitizers Induce Xenograft Tumor Regressions after Near-IR Laser Treatment through the Body of the Host Mouse , 2008, Clinical Cancer Research.
[26] M. Cook,et al. Investigation of zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine as an efficient photosensitizer by cyclic voltammetry , 2008 .
[27] H. Kitchener,et al. Clinical and Immunologic Results of a Phase II Trial of Sequential Imiquimod and Photodynamic Therapy for Vulval Intraepithelial Neoplasia , 2008, Clinical Cancer Research.
[28] W. Ahn,et al. Photodynamic therapy with recombinant adenovirus AdmIL‐12 enhances anti‐tumour therapy efficacy in human papillomavirus 16 (E6/E7) infected tumour model , 2008, Immunology.
[29] Keith A. Cengel,et al. Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific Antigen , 2008, Clinical Cancer Research.
[30] P. Morlière,et al. Photophysical properties of a photocytotoxic fluorinated chlorin conjugated to four β-cyclodextrins , 2008, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[31] Volker Albrecht,et al. Optimization of treatment parameters for Foscan®‐PDT of basal cell carcinomas , 2008, Lasers in surgery and medicine.
[32] N. Lange,et al. Combination of photodynamic therapy with anti-cancer agents. , 2008, Current medicinal chemistry.
[33] Y. Tamada,et al. Thioredoxin upregulation by 5‐aminolaevulinic acid‐based photodynamic therapy in human skin squamous cell carcinoma cell line , 2008, Photodermatology, photoimmunology & photomedicine.
[34] Wei Tang,et al. Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness. , 2008, Biochemical and biophysical research communications.
[35] T. Foster,et al. Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy. , 2008, Journal of biomedical optics.
[36] Michael R Hamblin,et al. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model , 2008, Proceedings of the National Academy of Sciences.
[37] D. Kessel,et al. Apoptotic and autophagic responses to Bcl-2 inhibition and photodamage , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[38] J. Woodhams,et al. The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[39] T. Vogl,et al. A Phase II safety and effect on time to tumor progression study of intratumoral light infusion technology using talaporfin sodium in patients with metastatic colorectal cancer , 2007, Journal of surgical oncology.
[40] A. Tedesco,et al. Characterization of biodegradable poly(D,L-lactide-co-glycolide) nanoparticles loaded with bacteriochlorophyll-a for photodynamic therapy. , 2007, Photomedicine and laser surgery.
[41] Michael R Hamblin,et al. Photodynamic therapy with fullerenes , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[42] M. Chopp,et al. Combination Therapy with Antiangiogenic Treatment and Photodynamic Therapy for the Nude Mouse Bearing U87 Glioblastoma , 2007, Photochemistry and photobiology.
[43] G. Maira,et al. m‐THPC‐mediated photodynamic therapy of malignant gliomas: Assessment of a new transfection strategy , 2007, International journal of cancer.
[44] B. Wilson,et al. Tetherless fiber-coupled optical sources for extended metronomic photodynamic therapy. , 2007, Photodiagnosis and photodynamic therapy.
[45] T. Hasan,et al. Strategies for Enhanced Photodynamic Therapy Effects † , 2007, Photochemistry and photobiology.
[46] B. Wilson,et al. Interstitial in vivo ALA-PpIX mediated metronomic photodynamic therapy (mPDT) using the CNS-1 astrocytoma with bioluminescence monitoring. , 2007, Photodiagnosis and photodynamic therapy.
[47] H. V. Snelling,et al. Two-photon excitation studies of m-THPC photosensitizer and photodynamic activity in an epithelial cell line. , 2007, Photodiagnosis and photodynamic therapy.
[48] C. Gomer,et al. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. , 2007, Cancer research.
[49] Shimon Weiss,et al. Singlet oxygen production by Peptide-coated quantum dot-photosensitizer conjugates. , 2007, Journal of the American Chemical Society.
[50] W. Ahn,et al. Photodynamic therapy‐generated tumor cell lysates with CpG‐oligodeoxynucleotide enhance immunotherapy efficacy in human papillomavirus 16 (E6/E7) immortalized tumor cells , 2007, Cancer science.
[51] R. Boyle,et al. Development and characterization of novel photosensitizer : scFv conjugates for use in photodynamic therapy of cancer , 2007, Immunology.
[52] Hui Li,et al. Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent. , 2007, Bioconjugate chemistry.
[53] Paras N Prasad,et al. Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. , 2007, Journal of the American Chemical Society.
[54] K. Berg,et al. Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells. , 2007, Molecular pharmaceutics.
[55] M. Korbelik,et al. Potentiation of photodynamic therapy of cancer by complement: the effect of γ-inulin , 2006, British Journal of Cancer.
[56] Henricus J C M Sterenborg,et al. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. , 2006, The Journal of investigative dermatology.
[57] S. Kusamura,et al. Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget's disease of the vulva: a pilot study. , 2006, Gynecologic oncology.
[58] David A Russell,et al. Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a ‘Trojan horse’ , 2006, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[59] Mladen Korbelik,et al. Photodynamic therapy-generated vaccine for cancer therapy , 2006, Cancer Immunology, Immunotherapy.
[60] Michael R Hamblin,et al. Photodynamic therapy and anti-tumour immunity , 2006, Nature Reviews Cancer.
[61] D. Nowis,et al. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity , 2006, Oncogene.
[62] T. Dougherty,et al. Endobronchial photodynamic therapy for lung cancer , 2006, Lasers in surgery and medicine.
[63] Mladen Korbelik,et al. PDT‐associated host response and its role in the therapy outcome , 2006, Lasers in surgery and medicine.
[64] Barbara Owczarczak,et al. Photodynamic therapy and anti‐tumor immunity , 2006, Lasers in surgery and medicine.
[65] B. Overholt,et al. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high‐grade dysplasia , 2006, Lasers in surgery and medicine.
[66] D. Kessel,et al. Initiation of apoptosis and autophagy by photodynamic therapy , 2006, Lasers in surgery and medicine.
[67] H. Kato,et al. Systemic Antitumor Effect of Intratumoral Injection of Dendritic Cells in Combination with Local Photodynamic Therapy , 2006, Clinical Cancer Research.
[68] J. Moan,et al. Radiosensitization of tumours by porphyrins. , 2006, Cancer letters.
[69] W. Sibbett,et al. Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy , 2006, The British journal of dermatology.
[70] Wei Chen,et al. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. , 2006, Journal of nanoscience and nanotechnology.
[71] Jicun Ren,et al. Luminescent quantum dots: a very attractive and promising tool in biomedicine. , 2006, Current medicinal chemistry.
[72] K. Berg,et al. Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[73] J. M. Marchetti,et al. Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. , 2006, International journal of pharmaceutics.
[74] Michael R Hamblin,et al. A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy , 2006, British Journal of Cancer.
[75] M. Novelli,et al. Photodynamic therapy with WST09 (Tookad): Quantitative studies in normal colon and transplanted tumours , 2006, International journal of cancer.
[76] H. Matsui,et al. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. , 2005, Biochemical pharmacology.
[77] K. Soo,et al. Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma. , 2005, International journal of molecular medicine.
[78] E. Eskelinen. Doctor Jekyll and Mister Hyde: autophagy can promote both cell survival and cell death , 2005, Cell Death and Differentiation.
[79] M. Tainsky,et al. A role for manganese superoxide dismutase in apoptosis after photosensitization. , 2005, Biochemical and biophysical research communications.
[80] M. Mason,et al. A phase‐1 study of sequential mitomycin C and 5–aminolaevulinic acid‐mediated photodynamic therapy in recurrent superficial bladder carcinoma , 2005, BJU international.
[81] Oliver J. Clarke,et al. The development and characterisation of porphyrin isothiocyanate–monoclonal antibody conjugates for photoimmunotherapy , 2005, British Journal of Cancer.
[82] Wei Tang,et al. Photodynamic Characterization and In Vitro Application of Methylene Blue-containing Nanoparticle Platforms¶ , 2005, Photochemistry and photobiology.
[83] Mladen Korbelik,et al. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. , 2005, Cancer research.
[84] Mladen Korbelik,et al. Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[85] Lothar Lilge,et al. Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶ , 2004, Photochemistry and photobiology.
[86] P. Mróz,et al. Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells , 2004, Clinical Cancer Research.
[87] C. Sibata,et al. Photosensitizers in clinical PDT. , 2004, Photodiagnosis and photodynamic therapy.
[88] J. Smolle,et al. Photodynamic therapy enhanced by hyperbaric oxygenation in palliation of malignant pleural mesothelioma: clinical experience. , 2004, Photodiagnosis and photodynamic therapy.
[89] Barbara W. Henderson,et al. Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors , 2004, Cancer Research.
[90] Ruomei Gao,et al. Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy , 2004 .
[91] R. Allman,et al. Investigation of sequential mitomycin C and photodynamic therapy in a mitomycin‐resistant bladder cancer cell‐line model , 2004, BJU international.
[92] Xiaobo Chen,et al. Semiconductor quantum dots for photodynamic therapy. , 2003, Journal of the American Chemical Society.
[93] W. Greco,et al. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors. , 2003, Cancer Research.
[94] P. Mróz,et al. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[95] Indrajit Roy,et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. , 2003, Journal of the American Chemical Society.
[96] B W Henderson,et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation , 2003, British Journal of Cancer.
[97] K. Okkenhaug,et al. Firefly luciferin-activated rose bengal: in vitro photodynamic therapy by intracellular chemiluminescence in transgenic NIH 3T3 cells. , 2003, Cancer research.
[98] Tayyaba Hasan,et al. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. , 2003, Cancer research.
[99] P. Mróz,et al. Antitumor Effects of Photodynamic Therapy Are Potentiated by 2-Methoxyestradiol , 2003, The Journal of Biological Chemistry.
[100] W. Potter,et al. A Beam‐splitting Device for Use with Fiber‐coupled Laser Light Sources for Photodynamic Therapy ¶ , 2002, Photochemistry and photobiology.
[101] Zheng Huang,et al. Preclinical Studies in Normal Canine Prostate of a Novel Palladium-Bacteriopheophorbide (WST09) Photosensitizer for Photodynamic Therapy of Prostate Cancer¶ , 2002, Photochemistry and photobiology.
[102] Zheng Huang,et al. Improvement of Tumor Response by Manipulation of Tumor Oxygenation During Photodynamic Therapy¶ , 2002, Photochemistry and photobiology.
[103] C. Gomer,et al. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. , 2002, Cancer research.
[104] A. Rainbow,et al. Up-regulation of Hsp27 Plays a Role in the Resistance of Human Colon Carcinoma HT29 Cells to Photooxidative Stress¶ , 2002 .
[105] Rik Roelandts,et al. The history of phototherapy: something new under the sun? , 2002, Journal of the American Academy of Dermatology.
[106] P. Mróz,et al. Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy-induced anemia. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[107] Kristian Berg,et al. Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy , 2002, Cancer Gene Therapy.
[108] Barbara W Henderson,et al. Generation of effective antitumor vaccines using photodynamic therapy. , 2002, Cancer research.
[109] B. McManus,et al. Fas ligand and TRAIL augment the effect of photodynamic therapy on the induction of apoptosis in JURKAT cells. , 2001, International immunopharmacology.
[110] M. Korbelik,et al. Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line , 2001, International journal of cancer.
[111] V. Dima,et al. New approach to the adoptive immunotherapy of Walker-256 carcinosarcoma with activated macrophages combined with photodynamic therapy. , 2001, Roumanian archives of microbiology and immunology.
[112] Freya Q. Schafer,et al. Phospholipid hydroperoxide glutathione peroxidase protects against singlet oxygen-induced cell damage of photodynamic therapy. , 2001, Free radical biology & medicine.
[113] M. Korbelik,et al. Interaction Between Photodynamic Therapy and BCG Immunotherapy Responsible for the Reduced Recurrence of Treated Mouse Tumors ¶ , 2001, Photochemistry and photobiology.
[114] K. Sano,et al. Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma , 2000, Cancer Immunology, Immunotherapy.
[115] L. Lilge,et al. Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue , 2000, British Journal of Cancer.
[116] K. Berg,et al. Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31‐gelonin , 2000, International journal of cancer.
[117] R. Allman,et al. Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neck , 2000, British Journal of Cancer.
[118] K. Berg,et al. Photochemical transfection: a new technology for light-induced, site-directed gene delivery. , 2000, Human gene therapy.
[119] A. Dabrowska,et al. Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF , 2000, British Journal of Cancer.
[120] A. E. Saarnak,et al. Biodistribution and Bioactivity of Tetra-pegylated Meta-tetra(hydroxyphenyl)chlorin Compared to Native Meta-tetra(hydroxyphenyl)chlorin in a Rat Liver Tumor Model , 2000 .
[121] M. Korbelik,et al. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. , 1999, Cancer research.
[122] H Anholt,et al. Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. , 1999, Cancer research.
[123] M. Obochi,et al. Photodynamic Alteration of the Surface Receptor Expression Pattern of Murine Splenic Dendritic Cells , 1999, Scandinavian journal of immunology.
[124] Michael R Hamblin,et al. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. , 1998, Cancer research.
[125] T. Mang,et al. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. , 1998, The cancer journal from Scientific American.
[126] M. Korbelik,et al. Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment. , 1998, Journal of photochemistry and photobiology. B, Biology.
[127] B. Henderson,et al. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. , 1998, British Journal of Cancer.
[128] B. Henderson,et al. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. , 1997, Cancer research.
[129] J. Krosl,et al. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. , 1996, Cancer research.
[130] J. Krosl,et al. Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. , 1996, Cancer research.
[131] J. Sessler,et al. Lutetium Texaphyrin (PCI‐0123): A Near‐Infrared, Water‐Soluble Photosensitizer , 1996, Photochemistry and photobiology.
[132] Z. Malik,et al. Photofrin II induces cytokine secretion by mouse spleen cells and human peripheral mononuclear cells. , 1996, Immunopharmacology.
[133] C. Gomer,et al. Decreased expression and function of alpha-2 macroglobulin receptor/low density lipoprotein receptor-related protein in photodynamic therapy-resistant mouse tumor cells. , 1995, Cancer research.
[134] Michael R Hamblin,et al. Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins. , 1994, Journal of photochemistry and photobiology. B, Biology.
[135] M. Korbelik,et al. Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG). , 1994, Cancer letters.
[136] J. K. Bradley,et al. Comparing the anti-tumor effect of several bioreductive drugs when used in combination with photodynamic therapy (PDT). , 1994, International journal of radiation oncology, biology, physics.
[137] J. Kanofsky,et al. QUENCHING OF SINGLET OXYGEN BY BIOMOLECULES FROM L1210 LEUKEMIA CELLS , 1992, Photochemistry and photobiology.
[138] B. Wilson,et al. RESISTANCE TO PHOTODYNAMIC THERAPY IN RADIATION INDUCED FIBROSARCOMA‐1 and CHINESE HAMSTER OVARY‐MULTI‐DRUG RESISTANT CELLS in vitro , 1991, Photochemistry and photobiology.
[139] C. Gomer,et al. INCREASED TRANSCRIPTION AND TRANSLATION OF HEME OXYGENASE IN CHINESE HAMSTER FIBROBLASTS FOLLOWING PHOTODYNAMIC STRESS OR PHOTOFRIN II INCUBATION , 1991, Photochemistry and photobiology.
[140] B. Lau,et al. Modulation of hematoporphyrin derivative-sensitized phototherapy with corynebacterium parvum in murine transitional cell carcinoma. , 1989, Urology.
[141] B W Henderson,et al. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice. , 1988, Cancer research.
[142] Q. Peng,et al. Photodynamic Therapy , 1988, Methods in Molecular Biology.
[143] C. Elmets,et al. In situ evidence for the involvement of superoxide anions in cutaneous porphyrin photosensitization. , 1988, Biochemical and biophysical research communications.
[144] B. Henderson,et al. The influence of cellular glutathione content on cell survival following photodynamic treatment in vitro. , 1986, Radiation research.
[145] D S Zaharko,et al. Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light. , 1983, Cancer research.
[146] Patrizia Agostinis,et al. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. , 2010, Biochimica et biophysica acta.
[147] M. Patterson,et al. In Vitro Survival of Nonsmall Cell Lung Cancer Cells Following Combined Treatment with Ionizing Radiation and Photofrin‐mediated Photodynamic Therapy , 2009, Photochemistry and photobiology.
[148] Malini Olivo,et al. Immune response against angiosarcoma following lower fluence rate clinical photodynamic therapy. , 2008, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[149] Steffen Jung,et al. Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity , 2008, Cancer Immunology, Immunotherapy.
[150] Xiu-yan Wang,et al. The facile synthesis and characterization of tetraimido-substituted zinc phthalocyanines , 2008 .
[151] Hong Liu,et al. Enhancement of Laser Cancer Treatment by a Chitosan-derived Immunoadjuvant¶ , 2005, Photochemistry and photobiology.
[152] H. Moseley,et al. Laser and Non-laser Light Sources for Photodynamic Therapy , 2002, Lasers in Medical Science.
[153] R. Nordquist,et al. Antitumor immunity induced by laser immunotherapy and its adoptive transfer. , 2001, Cancer research.
[154] J. Bhawalkar,et al. Two-photon photodynamic therapy. , 1997, Journal of clinical laser medicine & surgery.
[155] B. Steinberg,et al. Comparative biodistribution of meta‐Tetra (Hydroxyphenyl) chlorin in multiple species: Clinical implications for photodynamic therapy , 1997, Lasers in surgery and medicine.
[156] D. Bellnier. Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha. , 1991, Journal of photochemistry and photobiology. B, Biology.
[157] D. Bellnier. Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factors-α , 1991 .